{"id": "1337438243877388288", "creation": 1607705100.0, "user_id": "2570920968", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 1, "like_count": 0, "quote_count": 0}}, "text": "INOVIO and Advaccine Announce First Dosing of Subject in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China! $INO #COVID19 #vaccine\n#China\nhttps://t.co/RBpFN4D1tx https://t.co/kmslrRWHxo", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#CHINA"]}